Skye Bioscience, Inc. Post-effective amendment to a registration statement that is not immediately effective upon filing

Post-effective amendment to a registration statement that is not immediately effective upon filing

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Summary of Significant Accounting Policies (Policies)
Notes Tables
Notes Details

Related Party Matters (Detail Textuals)

v3.19.3.a.u2

Related Party Matters (Detail Textuals) - USD ($)			1 Months Ended		3 Months Ended		9 Months Ended		12 Months Ended
Related Party Matters (Detail Textuals) - USD ($)	Feb. 06, 2018	Apr. 01, 2017	Feb. 28, 2018	Jun. 30, 2014	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018	Dec. 31, 2017
Related Party Transaction [Line Items]
Total expense incurred under agreement						$ 0		$ 220,000
Independent contractor agreement \| K2C, Inc.
Related Party Transaction [Line Items]
Monthly fee		$ 20,000		$ 10,000
Total expense incurred under agreement									$ 220,000	$ 210,000
Independent contractor agreement \| Emerald Health Sciences Inc
Related Party Transaction [Line Items]
Initial term of agreement			10 years
Total expense incurred under agreement					$ 150,000	150,000	$ 450,000	400,000	550,000
Percentage of accrued interest on outstanding balance			12.00%
Separation and release agreement \| K2C, Inc.
Related Party Transaction [Line Items]
Lump sum payment in agreement			$ 180,000
Recognized additional stock based compensation expense of restricted stock and option awards								112,270	112,270
Separation and release agreement \| K2C, Inc. \| Immediate vesting
Related Party Transaction [Line Items]
Number of restricted common stock vested			900,000
Separation and release agreement \| K2C, Inc. \| October 20, 2015
Related Party Transaction [Line Items]
Number of restricted common stock vested			325,000
Separation and release agreement \| K2C, Inc. \| November 21, 2014
Related Party Transaction [Line Items]
Number of restricted common stock vested			125,000
Consulting Agreement \| Emerald Health Sciences Inc
Related Party Transaction [Line Items]
Initial term of agreement	1 year
Total expense incurred under agreement						$ 15,000		$ 45,000	$ 45,000
Annual fee	$ 60,000
Period of discretionary annual bonus payable to contractor after each fiscal year end	120 days

- Definition

Represents amount of annual fee.

+ References

No definition available.

+ Details

Name:	embi_AnnualFeeForAgreement
Namespace Prefix:	embi_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Represents the initial term of agreement.

+ References

No definition available.

+ Details

Name:	embi_InitialTermOfAgreement
Namespace Prefix:	embi_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount related to lump sum payment in the agreement.

+ References

No definition available.

+ Details

Name:	embi_LumpSumPaymentInAgreement
Namespace Prefix:	embi_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Represents amount of monthly fee.

+ References

No definition available.

+ Details

Name:	embi_MonthlyFee
Namespace Prefix:	embi_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Represents percentage of interest on accrued the outstanding balance

+ References

No definition available.

+ Details

Name:	embi_PercentageOfAccruedInterestOnOutstandingBalance
Namespace Prefix:	embi_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Period of discretionary annual bonus payable to contractor after each fiscal year end.

+ References

No definition available.

+ Details

Name:	embi_PeriodOfDiscretionaryAnnualBonusPayableToContractorAfterEachFiscalYearEnd
Namespace Prefix:	embi_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents total expense incurred under the agreement.

+ References

No definition available.

+ Details

Name:	embi_TotalExpenseIncurredUnderAgreement
Namespace Prefix:	embi_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5047-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.F)
-URI http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)(i)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901

+ Details

Name:	us-gaap_AllocatedShareBasedCompensationExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_RelatedPartyTransactionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(2)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_TypeOfArrangementAxis=embi_IndependentContractorAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=embi_K2CIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=embi_EmeraldHealthSciencesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=embi_SeparationAndReleaseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=embi_ConsultingAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: